Remove tag workforce
article thumbnail

Second unanimous FDA adcomm vote boosts bluebird bio

pharmaphorum

Beti-cel has already been approved for marketing in Europe as Zynteglo, with a price tag of around $1.8 million price tag, saying its ability to help patients reach sustained transfusion independence justified its high price. Beti-cel offers another potentially curative treatment for a much broader range of patients.

FDA 59
article thumbnail

The “Graziella Molinari Women in Pharma Award” Announced for 2022 Edition at the ISPE Italy Affiliate

ISPE

Winner of the ISPE Italy Affiliate’s Women in Pharma® Graziella Molinari Award in 2021, thanks to her project for the inclusion of #smart tags in a site production in order to improve not only efficiency, but also quality and compliance in a 4.0 Micaela Prati. perspective. . Learn More about Italy Affiliate.

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

bluebird unveils $2.8m price for gene therapy Zynteglo on FDA approval

pharmaphorum

million price tag attached to the therapy when it was first made available in Europe, and is also well above the proposed $2.1 It slashed its workforce by 30% to reduce cash burn and extend its funded operations into the first half of 2023, so investors will be looking for signs of take-up of Zynteglo in the coming months.

FDA 52
article thumbnail

Using Technology for Continuous Process Verification 4.0

ISPE

For example, based on benchmarking different cases, inserting four additional data points as tags into an existing data store would require an entire week of IT and QA collaboration. An increase in computing power requirements for AI model training brings a higher price tag, so careful planning is necessary to avoid surprises.

article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.